Repligen Corporation Company Profile

Repligen Corporation

41 Seyon St, Bldg #1, Ste 100
Waltham, MA 02453
United States
Tel: 1/781 250-0111
URL: http://www.repligen.com
Primary Symbol & Exchange:
RGEN - Common Stock - NASDAQ
Industry:
Biotechnology
+  SIC Industry Code:
+  NAICS Industry Code:
Mergers & Acquisitions:
Repligen Corporation Mergers and Acquisitions
Thomson Financial Business Description:
The Group's principal activity is to develop novel therapeutics primarily for radiology and neuropsychiatry. It currently sells a line of commercial products based on Protein A, which are used in the production of monoclonal antibodies. The Group manufactures and markets several products based on recombinant forms of Protein A. Its primary customers incorporate its Protein A products into their proprietary monoclonal antibody purification products that they sell directly to the biotechnology and pharmaceutical industry.
Alacra Alerts: Repligen Corporation RSS Feed  Subscribe with My Yahoo!
Receive alerts on the latest reports on Repligen Corporation

Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.

Premium Content Results:







Search for more premium content on Repligen Corporation